UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30,
2023
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 001-40625
RELATIVITY ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
Delaware | | 86-3244927 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
c/o 3753 Howard Hughes Pkwy Suite 200 Las Vegas, NV 89169 |
(Address of Principal Executive Offices, including zip code) |
(888) 710-4420 |
(Registrant’s telephone number, including area code) |
N/A |
(Former name, former address and former fiscal year, if changed since last report) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one share of Class A common stock and one redeemable warrant | | RACYU | | The Nasdaq Stock Market LLC |
Class A Common Stock, par value $0.0001 per share | | RACY | | The Nasdaq Stock Market LLC |
Redeemable warrants, each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 | | RACYW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether
the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
such files). Yes ☒ No ☐
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ☐ | Large accelerated filer | ☐ | Accelerated filer |
| ☒ | Non-accelerated filer | ☒ | Smaller reporting company |
| | | ☒ | Emerging growth company |
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether
the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐
As of November 20, 2023, there were 4,400,794 shares of Class A Common Stock, par value $0.0001 per share, and one share of Class B
Common Stock, par value $0.0001 per share, of the registrant issued and outstanding.
RELATIVITY ACQUISITION CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30,
2023
TABLE OF CONTENTS
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
RELATIVITY ACQUISITION CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
| |
September 30, 2023 | | |
December 31, 2022 | |
| |
(Unaudited) | | |
| |
Assets | |
| | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 25,939 | | |
$ | 1,429,804 | |
Prepaid expense | |
| 30,214 | | |
| 55,389 | |
Due from sponsor | |
| 3,047 | | |
| 3,047 | |
Total current assets | |
| 59,200 | | |
| 1,488,240 | |
Investments held in Trust Account | |
| 1,723,615 | | |
| 1,671,810 | |
Total Assets | |
$ | 1,782,815 | | |
$ | 3,160,050 | |
| |
| | | |
| | |
Liabilities, Redeemable Common Stock, and Stockholders’ (Deficit) Equity | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Due to related party | |
$ | 889 | | |
$ | 5,059 | |
Accrued costs and expenses | |
| 1,462,143 | | |
| 201,656 | |
Income tax payable | |
| — | | |
| 423,338 | |
Franchise tax payable | |
| 14,300 | | |
| 32,000 | |
Total current liabilities | |
| 1,477,332 | | |
| 662,053 | |
Warrant liabilities | |
| 707,853 | | |
| 453,122 | |
Total Liabilities | |
| 2,185,185 | | |
| 1,115,175 | |
| |
| | | |
| | |
Commitments and Contingencies (Note 6) | |
| | | |
| | |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized;
153,295 shares subject to possible redemption as of September 30, 2023 and December 31, 2022, at a redemption value of $11.13 and $11.78
per share, respectively (Note 3) | |
| 1,706,584 | | |
| 1,805,814 | |
| |
| | | |
| | |
Stockholders’ (Deficit) Equity: | |
| | | |
| | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of September 30, 2023 and December 2022 | |
| — | | |
| — | |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 4,247,499 and 653,750 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively (excluding 153,295 shares subject to possible redemption as of September 30, 2023 and December 31, 2022) | |
| 424 | | |
| 65 | |
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 1 and 3,593,750 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | |
| — | | |
| 359 | |
Additional paid-in capital | |
| — | | |
| — | |
Share subscription receivable | |
| | | |
| — | |
(Accumulated deficit) retained earnings | |
| (2,109,378 | ) | |
| 238,637 | |
Total Stockholder’s (Deficit) Equity | |
| (2,108,954 | ) | |
| 239,061 | |
Total Liabilities, Redeemable Common Stock, and Stockholders’ (Deficit) Equity | |
$ | 1,782,815 | | |
$ | 3,160,050 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
RELATIVITY ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| |
For the Three Months Ended September 30, | | |
For the Nine Months Ended September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
Formation and operating costs | |
$ | 667,382 | | |
| 255,500 | | |
| 2,109,560 | | |
| 874,541 | |
Loss from operations | |
| (667,382 | ) | |
| (255,500 | ) | |
| (2,109,560 | ) | |
| (874,541 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income (expense): | |
| | | |
| | | |
| | | |
| | |
Change in fair value of warrant liabilities | |
| — | | |
| 450,823 | | |
| (254,731 | ) | |
| 3,907,592 | |
Interest income on investments held in Trust Account | |
| 22,354 | | |
| 661,801 | | |
| 58,608 | | |
| 873,620 | |
Warrant issuance cost | |
| — | | |
| — | | |
| — | | |
| (125,175 | ) |
Total other income (expense), net | |
| 22,354 | | |
| 1,112,624 | | |
| (196,123 | ) | |
| 4,656,037 | |
| |
| | | |
| | | |
| | | |
| | |
(Loss) income before provision for income taxes | |
| (645,028 | ) | |
| 857,124 | | |
| (2,305,683 | ) | |
| 3,781,496 | |
Provision for income taxes | |
| (3,754 | ) | |
| (128,478 | ) | |
| (9,299 | ) | |
| (151,960 | ) |
Net (loss) income | |
$ | (648,782 | ) | |
| 728,646 | | |
| (2,314,982 | ) | |
| 3,629,536 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | |
| 153,295 | | |
| 15,028,750 | | |
| 153,295 | | |
| 12,496,433 | |
Basic and diluted net (loss) income per common stock, Class A common stock subject to possible redemption | |
$ | (0.15 | ) | |
| 0.04 | | |
| (0.53 | ) | |
| 0.23 | |
Basic and diluted weighted average shares outstanding, Class A common stock | |
| 4,247,499 | | |
| — | | |
| 3,494,397 | | |
| — | |
Basic and diluted net (loss) income per common stock, Class A common stock | |
$ | (0.15 | ) | |
| — | | |
| (0.53 | ) | |
| — | |
Basic and diluted weighted average shares outstanding, Class B common stock | |
| 1 | | |
| 3,593,750 | | |
| 753,103 | | |
| 3,593,750 | |
Basic and diluted net (loss) income per common stock, Class B common stock | |
$ | (0.15 | ) | |
| 0.04 | | |
| (0.53 | ) | |
| 0.23 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
RELATIVITY ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2023
| |
Class A Common Stock | | |
Class B Common Stock | | |
Additional Paid-in | | |
Share Subscription | | |
Accumulated | | |
Total Stockholders’ (Deficit) | |
| |
Share | | |
Amount | | |
Share | | |
Amount | | |
Capital | | |
Receivable | | |
Deficit | | |
Equity | |
Balance as of December 31, 2022 | |
| 653,750 | | |
$ | 65 | | |
| 3,593,750 | | |
$ | 359 | | |
$ | — | | |
$ | — | | |
$ | 238,637 | | |
$ | 239,061 | |
Conversion of Class B shares to Class A shares | |
| 3,593,749 | | |
| 359 | | |
| (3,593,749 | ) | |
| (359 | ) | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (13,047 | ) | |
| (13,047 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,301,762 | ) | |
| (1,301,762 | ) |
Balance as of March 31, 2023 (unaudited) | |
| 4,247,499 | | |
| 424 | | |
| 1 | | |
| — | | |
| — | | |
| — | | |
| (1,076,172 | ) | |
| (1,075,748 | ) |
Accretion for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (13,386 | ) | |
| (13,386 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (364,438 | ) | |
| (364,438 | ) |
Balance as of June 30, 2023 (unaudited) | |
| 4,247,499 | | |
| 424 | | |
| 1 | | |
| — | | |
| — | | |
| — | | |
| (1,453,996 | ) | |
| (1,453,572 | ) |
Accretion for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (6,600 | ) | |
| (6,600 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (648,782 | ) | |
| (648,782 | ) |
Balance as of September 30, 2023 (unaudited) | |
| 4,247,499 | | |
$ | 424 | | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | (2,109,378 | ) | |
| (2,108,954 | ) |
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2022
| |
Class A Common Stock | | |
Class B Common Stock | | |
Additional Paid-in | | |
Share Subscription | | |
Accumulated | | |
Total Stockholders’ (Deficit) | |
| |
Share | | |
Amount | | |
Share | | |
Amount | | |
Capital | | |
Receivable | | |
Deficit | | |
Equity | |
Balance as of December 31, 2021 | |
| — | | |
$ | — | | |
| 3,593,750 | | |
$ | 359 | | |
$ | 1,999,509 | | |
$ | (2,470 | ) | |
$ | (7,102 | ) | |
$ | 1,990,296 | |
Sale of 653,750 private placement units, net of private warrants liability | |
| 653,750 | | |
| 65 | | |
| — | | |
| — | | |
| 6,327,803 | | |
| — | | |
| — | | |
| 6,327,868 | |
Payment of subscription receivable | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,470 | | |
| — | | |
| 2,470 | |
Accretion for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| (8,327,312 | ) | |
| — | | |
| (2,913,095 | ) | |
| (11,240,407 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,389,668 | | |
| 1,389,668 | |
Balance as of March 31, 2022 (unaudited) | |
| 653,750 | | |
| 65 | | |
| 3,593,750 | | |
| 359 | | |
| — | | |
| — | | |
| (1,530,529 | ) | |
| (1,530,105 | ) |
Remeasurement for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (88,337 | ) | |
| (88,337 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,511,222 | | |
| 1,511,222 | |
Balance as of June 30, 2022 (unaudited) | |
| 653,750 | | |
| 65 | | |
| 3,593,750 | | |
| 359 | | |
| — | | |
| — | | |
| (107,644 | ) | |
| (107,220 | ) |
Remeasurement for Class A common stock to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (483,323 | ) | |
| (483,323 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 728,646 | | |
| 728,646 | |
Balance as of September 30, 2022 (unaudited) | |
| 653,750 | | |
$ | 65 | | |
| 3,593,750 | | |
$ | 359 | | |
$ | — | | |
$ | — | | |
$ | 137,679 | | |
$ | 138,103 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
RELATIVITY ACQUISITION CORP.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| |
For the Nine Months Ended September 30, | |
| |
2023 | | |
2022 | |
Cash flows from operating activities: | |
| | |
| |
Net (loss) income | |
$ | (2,314,982 | ) | |
$ | 3,629,536 | |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |
| | | |
| | |
Interest income on investments held in Trust Account | |
| (58,608 | ) | |
| (873,620 | ) |
Warrant issuance cost | |
| — | | |
| 125,175 | |
Change in fair value of warrant liabilities | |
| 254,731 | | |
| (3,907,592 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expense | |
| 25,175 | | |
| (175,337 | ) |
Due from sponsor | |
| — | | |
| (3,047 | ) |
Accrued costs and expenses | |
| 1,260,487 | | |
| 75,000 | |
Income taxes payable | |
| (423,338 | ) | |
| 300,455 | |
Franchise tax payable | |
| (17,700 | ) | |
| — | |
Due to related party | |
| (4,170 | ) | |
| 5,059 | |
Net cash used in operating activities | |
| (1,278,405 | ) | |
| (824,371 | ) |
Cash flows from investing activities: | |
| | | |
| | |
Investment of cash in Trust Account, net | |
| 6,803 | | |
| (146,625,000 | ) |
Net cash provided by (used in) investing activities | |
| 6,803 | | |
| (146,625,000 | ) |
Cash flows from financing activities: | |
| | | |
| | |
Proceeds from initial public offering, net of underwriters’ discount | |
| — | | |
| 142,312,500 | |
Proceeds from private placement units | |
| — | | |
| 6,537,500 | |
Proceeds from issuance of promissory note – related party | |
| — | | |
| 111,800 | |
Proceeds from payment of share subscription receivable | |
| — | | |
| 2,470 | |
Payment of promissory note – related party | |
| — | | |
| (208,563 | ) |
Payment of offering costs | |
| — | | |
| (411,456 | ) |
Redemption of ordinary shares | |
| (132,263 | ) | |
| — | |
Net cash (used in) provided by financing activities | |
| (132,263 | ) | |
| 148,344,251 | |
Net change in cash | |
| (1,403,865 | ) | |
| 894,880 | |
Cash, beginning of the period | |
| 1,429,804 | | |
| 42,194 | |
Cash, end of the period | |
$ | 25,939 | | |
$ | 937,074 | |
| |
| | | |
| | |
Supplemental disclosure of cash flow information: | |
| | | |
| | |
Income taxes paid | |
$ | 440,137 | | |
$ | — | |
The excess of fair value of A.G.P. shares that were included in deferred offering costs | |
$ | — | | |
$ | 1,972,398 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
RELATIVITY ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2023
Note 1 — Organization and Business Operations
Relativity Acquisition Corp.
(the “Company”) is a blank check company incorporated as a Delaware corporation on April 13, 2021, for the purpose of
effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one
or more businesses (the “Business Combination”). The Company may pursue an initial Business Combination target in any business
or industry.
As of September 30, 2023,
the Company had not commenced any operations. All activity for the period from April 13, 2021 (inception) through September 30, 2023
relates to the Company’s formation and the initial public offering (“IPO”), described below, and identifying a target
company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business
Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived
from the IPO.
The Company has selected
December 31 as its fiscal year end.
The sponsor is Relativity
Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”).
The registration statement
for the Company’s IPO was declared effective on February 10, 2022 (the “Effective Date”). On February 15, 2022, the
Company consummated the IPO of 14,375,000 units at $10.00 per unit (the “Units”), including the issuance of 1,875,000 units
as a result of the full exercise of the underwriters’ over-allotment option, which is discussed in Note 3. Each Unit consists of
one share of Class A common stock and one redeemable warrant (“Public Warrant”). Each whole warrant entitles the holder to
purchase one share of the Company’s Class A common stock at a price of $11.50 per share.
Simultaneously with the consummation
of the IPO, including 1,875,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional
units to cover over-allotments, the Company consummated the private placement of 653,750 units (the “Private Placement
Units”) to the Sponsor, at a price of $10.00 per Private Placement Unit in a private placement. Each Private Placement Unit
consists of one share of Class A common stock and one warrant (“Private Placement Warrant”).
Transaction costs amounted
to $3,890,326, consisting of $1,437,500 of underwriting commissions, $1,972,398 of the excess of the fair value of Class
B common stock issued to underwriter over the share subscription receivable and $480,428 of other offering costs.
The Company’s management
has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Units,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
The initial Business Combination
must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held
in the Trust Account (as defined below) (excluding the amount of the business combination fee held in trust and taxes payable on the income
earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with the initial Business
Combination. However, the Company will only complete an initial Business Combination if the post-transaction company owns or acquires 50%
or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it
not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment
Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.
Following the closing of
the IPO and full exercise of the over-allotment by the underwriters on February 15, 2022, $146,625,000 ($10.20 per Unit) from the net
proceeds of the sale of the Units in the IPO and the sale of the Private Placement Units was deposited into a trust account (the “Trust
Account”) and will be invested only in U.S. government securities with a maturity of 185 days or less or in money market
funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government
treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company
to pay the Company’s franchise and income tax obligations (less up to $100,000 of interest to pay dissolution expenses), the net
proceeds from the IPO and the sale of the Private Placement Units will not be released from the Trust Account until the earliest
of (a) the completion of the initial Business Combination, (b) the redemption of any public shares properly submitted in connection
with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance
or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business
Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’
rights or pre-Business Combination activity, and (c) the redemption of the public shares if the Company is unable to complete the
initial Business Combination within the Combination Period (as defined below), subject to applicable law. The proceeds deposited in the
Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of
the public stockholders.
The Company will provide
its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) without a
stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed Business
Combination or conduct a tender offer will be made by the Company, solely in the Company’s discretion.
The Company will provide
its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business
days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and
not previously released to the Company to pay the Company’s franchise and income taxes, divided by the number of then outstanding
public shares, subject to the limitations described herein. The amount in the Trust Account initially was $10.20 per public share.
The per-share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the business combination
fee the Company will pay to the underwriters. There will be no redemption rights upon the completion of the initial Business Combination
with respect to the Company’s warrants.
The shares of common stock
subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO in accordance
with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing
Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company’s Class A
common stock is not a “penny stock” upon such consummation of a Business Combination and, if the Company seeks stockholder
approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.
The Company had 12 months from the closing of the IPO to complete the initial
Business Combination, except that the Sponsor had two 3-month extensions available to it for a total of up to 18 months to complete the
initial Business Combination (as set out below). On December 21, 2022, the Company held a special meeting of stockholders (the “Meeting”)
in which the stockholders approved an amendment to the Company’s second amended and restated certificate of incorporation to extend
the date by which the Company must consummate its initial Business Combination from February 15, 2023 to August 15, 2023, by which is
was required to pay $10,000 in the Trust Account. The Sponsor was permitted to extend the period of time to consummate a Business Combination
for up to two times without stockholder approval, each for an additional three months (for a total of up to 24 months to complete a Business
Combination (each such three-month period, a “Funded Extension Period”)), so long as the Company deposited an aggregate amount
of $1,000 from its working capital into the trust account no later than the 21-month and 24-month anniversary of its IPO for each such
extension that the Company determines to implement. The public stockholders were not entitled to vote or redeem their shares in connection
with any Funded Extension Periods. On August 7, 2023,the Company announced that it had extended the date by which it has to consummate
a Business Combination from August 15, 2023 to November 15, 2023, which is the first of two Funded Extension Periods. On November 9, 2023,
the Company announced that it had extended the date by which it has to consummate a Business Combination from November 15, 2023 to February
15, 2024 (the “Combination Period”). In accordance with the Sponsor’s request and with the Company’s current charter,
an aggregate amount of $1,000 from Relativity’s working capital was deposited into the Trust Account on August 3, 2023 and November
9, 2023, respectively.
In connection with the stockholders’
vote at the Meeting, 14,221,705 shares were submitted for redemption. In connection with the redemptions of public shares, a
total of $133,689 was withdrawn from the Company’s trust account in order to pay taxes prior to the Special Meeting, which amount had later been
determined to be withheld in excess and should be returned to the public stockholders. As such, a portion of this rebate was sent to the
financial institutions that had submitted share redemptions on behalf of their investor clients ahead of the Special Meeting and the balance
to the trust account. The redemption rebate payments total $132,263 ($0.00930008 per redeemed share), with $1,426 returned to the trust
account.
If the Company is unable
to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the
funds held in the Trust Account and not previously released to the Company to pay the Company’s franchise and income taxes (less
up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will
completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions,
if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to
the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor, officers, directors
and initial stockholders of the Company have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)
waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the
completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public shares
in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation
(A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete
the initial Business Combination within the Combination Period; or (B) with respect to any other provision relating to stockholders’
rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with
respect to their founder shares and private placement shares if the Company fails to complete the initial Business Combination within
the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any public
shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame; and (iv) vote any
founder shares held by them and any public shares purchased during or after the IPO (including in open market and privately-negotiated
transactions) in favor of the initial Business Combination.
The Sponsor has agreed that
it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement
or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per public share
and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.20 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held
in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of
the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not
asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has
sufficient funds to satisfy its indemnity obligations, and the Company believes that the Sponsor’s only assets are securities of
the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations.
On January 12, 2023,
the Company received a determination letter (the “Letter”) from the Nasdaq Listing Qualifications staff (the
“Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with
the requirements of the Nasdaq Listing Rules set forth in (i) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market
Value of Listed Securities, (ii) Listing Rule 5450(b)(2)(B), requiring a minimum 1,100,000 Publicly Held Shares, and (iii) Listing
Rule 5450(b)(2)(C), requiring a minimum of $15 million in Market Value of Publicly Held Shares. In addition, the Letter stated that
the Company did not comply with either of the alternative requirements for continued listing on The Nasdaq Global Market under
Listing Rules 5450(b)(1) or 5450(b)(3), or the requirements for continued listing on The Nasdaq Capital Market under Listing Rule
5550. The Letter also indicated that the Staff had concerns that the Company might no longer comply with the minimum 400 Total
Holders requirement of Listing Rule 5450(a)(2) due to the substantial number of shareholder redemptions and low number of shares
remaining outstanding. Additionally, the Letter indicated that, while companies are normally afforded compliance periods or the
ability to submit a plan of compliance in order to be granted time to regain compliance, the Staff had determined to apply a more
stringent criteria as permitted under Nasdaq Listing Rule 5101 to delist the Company’s securities from The Nasdaq Global
Market. As a result, the Letter indicated that the Staff had determined to delist the Company’s securities from The Nasdaq
Global Market. The Staff’s determination was based on the Company’s Current Report on Form 8-K filed with Securities and
Exchange Commission (the “SEC”) on December 28, 2022, in which the Company disclosed that holders of 14,221,705 shares
of Class A common stock exercised their redemption rights in connection with a special meeting of stockholders held on December 21,
2022.
In addition, on January 11,
2023, the Staff determined to halt trading in the Company’s securities (the “Trading Halt”). The Company requested a
hearing before the Nasdaq Hearings Panel (the “Panel”) to appeal the Staff’s delisting determination. A hearing request
stays any suspension or delisting of the Company’s securities, and the Company’s securities continued to be listed on The
Nasdaq Global Market until the hearing process concluded and the Panel issued a written decision following the hearing. At this juncture,
the Company is unable to provide assurance as to if and when the trading halt will be released.
On March 2, 2023, Relativity
had a hearing before the Panel to appeal the Staff’s delisting determination. After the hearing, the Panel requested additional
information from Relativity, which was provided on April 12, 2023. On April 20, 2023, the Panel granted Relativity’s request to
continue the listing of its securities on the Nasdaq Capital Market. However, the Panel did not remove the Trading Halt. As of the date
of the issuance of these unaudited condensed consolidated financial statements, the Trading Halt is still in place. There can be no assurance
that the Trading Halt will be lifted prior to the Closing of the Business Combination.
Risks and Uncertainties
Results of operations and
the Company’s ability to complete an initial Business Combination may be adversely affected by various factors that could cause
economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by,
among other things, downturns in the financial markets or in economic conditions, inflation, increases in interest rates, adverse developments
affecting the financial services industry, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot
at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they
may negatively impact the Company’s business and its ability to complete an initial Business Combination. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Consideration of IR Act Excise Tax
On August 16, 2022, the Inflation
Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S.
federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries
of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation
itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value
of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations
are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the
same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”)
has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase
that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise
tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote
or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection
with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any
“PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business
Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance
from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics
of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand
to complete a Business Combination and in the Company’s ability to complete a Business Combination.
Liquidity, Capital Resources and Going Concern
As of September 30, 2023, the Company had $25,939 in its operating
bank account and a working capital deficit of $1,418,132.
The Company will need to
raise additional funds in order to meet the expenditures required for operating the business. In order to finance transaction costs in
connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s
officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”).
If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the
Trust Account released to the Company. In the event that the initial Business Combination does not close, the Company may use a portion
of the working capital held outside the Trust Account to repay the Working Capital Loans, but no proceeds from the Trust Account would
be used to repay the Working Capital Loans. Up to $1,500,000 of such working capital loans may be convertible into private placement-equivalent
units at a price of $10.00 per unit (which, for example, would result in the holders being issued 150,000 units if $1,500,000 of notes
were so converted) at the option of the lender. Such units would be identical to the Private Placement Units. The terms of such working
capital loans by the Sponsor or its affiliates, or the Company’s officers and directors, if any, have not been determined and no
written agreements exist with respect to the Working Capital Loans. The Company does not expect to seek loans from parties other than
the Sponsor or an affiliate of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide
a waiver against any and all rights to seek access to funds in the Trust Account. At September 30, 2023 and December 31, 2022, no such
Working Capital Loans were outstanding.
In connection with the Company’s
assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) Topic 2014-15, “Disclosures
of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until February 15, 2024 (absent
any extensions of such period, pursuant to the terms described above) to consummate the proposed Business Combination. It is uncertain
whether the Company will be able to consummate the proposed Business Combination by this date. If a Business Combination is not consummated
by this date, unless that time is extended (as provided above, or pursuant to a stockholder vote), there will be a mandatory liquidation
and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a
Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue
as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate
by February 15, 2024. The Company intends to complete the proposed Business Combination before the end of the Combination Period. However,
there can be no assurance that the Company will be able to consummate any Business Combination by the end of the Combination Period.
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited
condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted
in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC.
Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited
condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the
fair statement of the balances and results for the periods presented. The interim results for the three and nine months ended September
30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim
periods. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial
statements and notes thereto included in the Form 10-K filed by the Company with the SEC on March
31, 2023.
Principles of Consolidation
The accompanying condensed
consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Relativity Holdings Inc. There
has been no intercompany activity since inception.
Emerging Growth Company Status
The Company is an “emerging
growth company,” as defined in Section 2 (a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act of 1934 (the “Exchange Act”)) are required to comply with the new or
revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company
has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different
application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at
the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with
another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended
transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited
condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed
consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those
estimates.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from those estimates. The Company has determined the more significant accounting estimates included in the
condensed consolidated financial statements is the determination of the fair value of derivative financial instruments as described below.
Cash and Cash Equivalents
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30,
2023 and December 31, 2022, the Company had cash of $25,939 and $1,429,804, respectively. The Company did not have any cash equivalents
as of September 30, 2023 and December 31, 2022.
Investment Held in Trust Account
As of September 30, 2023
and December 31, 2022, the Company had $1,723,615 and $1,671,810, respectively, in investments held in the Trust Account that were held
in money market funds which are primarily invested in U.S. treasury securities. Net proceeds of the sale of the Units in the IPO and the
sale of the Private Placement Units were placed in the Trust Account which will only be invested in United States “government securities”
within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.
The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the
condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in
fair value of warrant liability are included in interest income on investments held in Trust Account in the accompanying condensed consolidated
statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Deferred Offering Costs
Offering costs consist of
accounting and legal expenses incurred through the condensed consolidated balance sheet date that are directly related to the IPO, and
the excess of the fair value of Class B common stock issued to underwriter over the share subscription receivable. Offering costs will
be allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds
received. Upon completion of the IPO, offering costs associated with warrant liabilities were expensed and offering costs associated with
the Class A common stock were charged to temporary equity.
Fair Value of Financial Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and
Disclosures,” approximates the carrying amounts represented in the condensed consolidated balance sheets, primarily due to its short-term
nature (except for the warrant liabilities – see Note 8).
Fair value is defined as
the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants
at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Company’s financial instruments are classified
as either Level 1, Level 2 or Level 3. These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Derivative Financial Instruments
The Company evaluates its
financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance
with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities,
the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with
changes in the fair value reported in the condensed consolidated statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative
liabilities are classified in the condensed consolidated balance sheets as current or non-current based on whether or not net-cash settlement
or conversion of the instrument could be required within 12 months of the condensed consolidated balance sheet date.
Net (Loss) Income per Common Stock
The Company has two
classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata
between the two classes of shares. The 15,028,750 shares of Class A common stock from the outstanding warrants to purchase the
Company’s shares were excluded from diluted earnings per share for the three and nine months ended September 30, 2023 because
the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, basic and diluted net (loss)
income per Class A share is the same for the period. The table below presents a reconciliation of the numerator and denominator used
to compute basic and diluted net (loss) income per share for each class of common stock.
At September 30, 2023, the
Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted and basic (loss) income per Class B share is the same for the period.
The following tables present
a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of common
stock:
| |
For the Three Months Ended | |
| |
September 30, | |
| |
2023 | | |
2022 | |
Class A Common Stock subject to possible redemption | |
| | |
| |
Numerator: Net (loss) income allocable to Class A common stock | |
$ | (22,599 | ) | |
$ | 588,033 | |
Denominator: Weighted Average Class A common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 153,295 | | |
| 15,028,750 | |
Basic and diluted net (loss) income per share | |
$ | (0.15 | ) | |
$ | 0.04 | |
| |
| | | |
| | |
Class A Common Stock | |
| | | |
| | |
Numerator: Net (loss) income allocable to Class A common stock | |
$ | (626,183 | ) | |
$ | — | |
Denominator: Weighted Average Class A common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 4,247,499 | | |
| — | |
Basic and diluted net (loss) income per share | |
$ | (0.15 | ) | |
$ | — | |
| |
| | | |
| | |
Class B Common Stock | |
| | | |
| | |
Numerator: Net (loss) income allocable to Class B common stock | |
$ | (0 | ) | |
$ | 140,613 | |
Denominator: Weighted Average Class B common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 1 | | |
| 3,593,750 | |
Basic and diluted net (loss) income per share | |
$ | (0.15 | ) | |
$ | 0.04 | |
| |
For the Nine Months Ended | |
| |
September 30, | |
| |
2023 | | |
2022 | |
Class A Common Stock subject to possible redemption | |
| | |
| |
Numerator: Net (loss) income allocable to Class A common stock | |
$ | (80,639 | ) | |
$ | 2,832,783 | |
Denominator: Weighted Average Class A common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 153,295 | | |
| 12,496,433 | |
Basic and diluted net (loss) income per share | |
$ | (0.53 | ) | |
$ | 0.23 | |
| |
| | | |
| | |
Class A Common Stock | |
| | | |
| | |
Numerator: Net (loss) income allocable to Class A common stock | |
$ | (1,838,183 | ) | |
$ | — | |
Denominator: Weighted Average Class A common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 3,494,397 | | |
| — | |
Basic and diluted net (loss) income per share | |
$ | (0.53 | ) | |
$ | — | |
| |
| | | |
| | |
Class B Common Stock | |
| | | |
| | |
Numerator: Net (loss) income allocable to Class B common stock | |
$ | (396,160 | ) | |
$ | 796,753 | |
Denominator: Weighted Average Class B common stock | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 753,103 | | |
| 3,593,750 | |
Basic and diluted net (loss) income per share | |
$ | (0.53 | ) | |
$ | 0.23 | |
Income Taxes
The Company accounts for
income taxes under ASC Topic 740, “Income Taxes.” ASC Topic 740, requires the recognition of deferred tax assets and liabilities
for both the expected impact of differences between the unaudited condensed consolidated financial statements and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC Topic 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded
against it. The Company’s effective tax rate was 0.30% and 14.99% for the three months ended September 30, 2023 and 2022, respectively,
and 0.30% and 4.02% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory
tax rate of 21% for the three and nine months ended September 30, 2023, due to changes in fair value in warrant liability and the valuation
allowance on the deferred tax assets.
ASC Topic 740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
ASC Topic 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure
and transition.
The Company recognizes accrued
interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts
accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position.
The Company has identified
the United States as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities
since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of
unrecognized tax benefits will materially change over the next twelve months.
Common Stock Subject to Possible Redemption
The Company’s Class
A common stock that was sold as part of the Units in the IPO contains a redemption feature which allows for the redemption of such public
shares in connection with the Company’s liquidation, or if there is a stockholder vote or tender offer in connection with the Company’s
initial Business Combination. In accordance with ASC 480-10-S99, the Company classified the 14,375,000 shares subject to redemption outside
of permanent equity as the redemption provisions are not solely within the control of the Company. The public shares sold as part of the
Units in the IPO were issued with other freestanding instruments (i.e., Public Warrants), and as such, the initial carrying value of public
shares is classified as temporary equity.
On December 21, 2022, the
Company held the Meeting. At the Meeting, the Company’s stockholders approved an amendment to the Company’s second amended
and restated certificate of incorporation (the “Charter Amendment”) to extend the date by which the Company must consummate
its initial Business Combination from February 15, 2023 to August 15, 2023 or such earlier date as determined by the Company’s Board
of Directors, and to provide for up to two additional three-month extensions beyond August 15, 2023 for the period of time for the Company
to consummate an initial Business Combination. In connection with the Meeting, stockholders holding 14,221,705 shares of Class A common
stock exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. As a result,
approximately $146 million (approximately $10.29 per Public Share) was removed from the Trust Account to pay such holders and approximately
$1.6 million remained in the Trust Account. Following redemptions, the Company has 153,295 Public Shares outstanding as of September 30,
2023 and December 31, 2022.
Concentration of Credit Risk
The Company had significant cash balances at financial institutions
which throughout the year regularly exceeded the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds
could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.
Recent Accounting Standards
In August 2020, FASB issued
ASU Topic 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts
in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years, with early adoption permitted. The Company early adopted ASU 2020-06 effective
as of April 13, 2021. The adoption of ASU 2020-06 did not have an impact on the Company’s condensed consolidated financial statements.
Management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on
the Company’s unaudited condensed consolidated financial statements.
Note 3 — Initial Public Offering
On February 15, 2022, the
Company consummated its IPO of 14,375,000 Units, including 1,875,000 Units sold pursuant to the full exercise of the
underwriters’ option to purchase additional units to cover over-allotments, at a purchase price of $10.00 per Unit. Each Unit
consists of one share of Class A common stock and one redeemable Public Warrant. Each whole Public Warrant will entitle the holder
to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).
Following the closing of
the IPO on February 15, 2022, $146,625,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the
sale of the Private Placement Units was placed in a Trust Account and will be invested only in U.S. government securities with a maturity
of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest
only in direct U.S. government treasury obligations.
All of the 14,375,000 shares
of Class A common stock sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public
shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business
Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC guidance
on redeemable equity instruments, which has been codified in ASC Topic 480-10-S99, redemption provisions not solely within the control
of the Company require common stock subject to redemption to be classified outside of permanent equity.
Accordingly, at September
30, 2023 and December 31, 2022, 153,295 shares of common stock subject to possible redemption are presented at redemption value of $11.13
and $11.78 per share, as temporary equity, outside of the stockholders’ (deficit) equity section of the Company’s condensed
consolidated balance sheets, respectively.
The shares of Class A common
stock are accounted for in accordance with the guidance in ASC Topic 480-10-S99. If it is probable that the equity instrument will become
redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or
from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument
or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the
redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately
upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the
carrying value of redeemable common stock resulted in charges against additional paid-in capital and accumulated deficit.
As of September 30, 2023
and December 31 2023, the common stock subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled
in the following table:
Gross proceeds from IPO | |
$ | 143,750,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (4,600,256 | ) |
Class A common stock issuance cost | |
| (3,765,151 | ) |
Redemptions | |
| (146,413,246 | ) |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 12,834,467 | |
Common stock subject to possible redemption, December 31, 2022 | |
| 1,805,814 | |
Less: | |
| | |
Redemptions | |
| (132,263 | ) |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 13,047 | |
Common stock subject to possible redemption, March 31, 2023 | |
| 1,686,598 | |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 13,386 | |
Common stock subject to possible redemption, June 30, 2023 | |
$ | 1,699,984 | |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 6,600 | |
Common stock subject to possible redemption, September 30, 2023 | |
$ | 1,706,584 | |
Note 4 — Private Placement
Simultaneously with the closing
of the IPO, the Company’s Sponsor purchased an aggregate of 653,750 Private Placement Units at a price of $10.00 per
Unit, or $6,537,500 in the aggregate, in a private placement. Each Private Placement Unit consists of one share of Class A common
stock and one Private Placement Warrant.
The Private Placement Warrants
will be non-redeemable and exercisable on a cashless basis so long as they are held by the sponsor or its permitted transferees. If the
Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will
be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the
IPO.
Note 5 — Related Party Transactions
Founder Shares
In May 2021, the Sponsor
paid $25,000 of deferred offering costs on behalf of the Company in exchange for 3,750,000 shares of common stock (the
“Founder Shares”). On December 14, the Sponsor returned to the Company, at no cost, an aggregate of 511,250 Founder
Shares, which the Company cancelled. On December 14, 2021, an aggregate of 355,000 shares of Class B common stock
were issued to A.G.P. (the “Representative”), resulting in an aggregate of 3,593,750 shares of Class B common
stock outstanding. On January 12, 2022, the Sponsor transferred 176,094 Founder Shares to George Syllantavos, and 28,750 Founder
Shares to Anastasios Chrysostomidis. The number of Founder Shares outstanding was determined based on the expectation that the total size
of the IPO would be a maximum of 14,375,000 Units if the underwriters’ over-allotment option were exercised in full,
and therefore that such Founder Shares would represent 20% of the outstanding shares after the IPO. The underwriters’ over-allotment
option was exercised in full, and no Founder Shares were forfeited.
On February 27, 2023, the
Company issued an aggregate of 3,593,749 shares of Class A common stock to the sponsor, A.G.P., George Syllantavos and Anastasios Chrysostomidis,
the holders of the Class B common stock, upon the conversion of an equal number of shares of Class B common stock. These shares of class
A common stock are subject to the same restrictions as applied to the Class B common stock before the conversion, including, among other
things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination
as described in the prospectus for the initial public offering. Following the conversion, the sponsor was the beneficial owner of 3,033,905
shares of Class A common stock and one share of Class B common stock. The sponsor then transferred 533,525 shares of Class A common stock
to certain members of the sponsor. Subsequent to those transfers, the sponsor holds 2,500,380 shares of Class A common stock and one share
of Class B common stock, as well as 653,750 shares of Class A common stock underlying private placement units, which units were acquired
by the sponsor in connection with the Company’s initial public offering.
Following the redemptions
and the conversion of Class B common stock into shares of Class A common stock, there are currently 153,295 public shares outstanding
and a total of 4,400,794 shares of Class A common stock and one share of Class B Common stock are outstanding, including the 2,500,380
shares of Class A common stock and the one share of Class B common stock that are beneficially owned by the sponsor.
The initial stockholders
have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i) six months after the
date of the consummation of the initial Business Combination or (ii) the date on which the Company consummates a liquidation, merger,
stock exchange or other similar transaction which results in all of the stockholders having the right to exchange their shares of Class A
common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements
of the initial stockholders with respect to any Founder Shares. Notwithstanding the foregoing, if the closing price of the shares of Class A
common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after the initial Business
Combination, the Founder Shares will no longer be subject to such transfer restrictions.
Promissory Note — Related Party
On July 2, 2021, the Sponsor
agreed to loan the Company up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”).
This loan was non-interest bearing and payable on the earlier of March 31, 2022 or the completion of the IPO. The outstanding balance
under the promissory note of $208,563 was paid in full and as a result, the credit facility is no longer available.
Working Capital Loans
In order to finance transaction
costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s
officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”).
If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the
Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account.
In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the
Trust Account to repay the Working Capital Loans, but no proceeds from the Trust Account would be used to repay the Working Capital Loans.
Up to $1,500,000 of such working capital loans may be convertible into private placement-equivalent units at a price of $10.00 per
unit (which, for example, would result in the holders being issued 150,000 units if $1,500,000 of notes were so converted)
at the option of the lender. Such units would be identical to the Private Placement Units. The terms of such working capital loans by
the Sponsor or its affiliates, or the Company’s officers and directors, if any, have not been determined and no written agreements
exist with respect to the Working Capital Loans. The Company does not expect to seek loans from parties other than the Sponsor or an affiliate
of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all
rights to seek access to funds in the Trust Account. At September 30, 2023 and December 31, 2022, no such Working Capital Loans were outstanding.
Administrative Service Fee
The Company entered into
an administrative services agreement on the effective date of the registration statement for the IPO pursuant to which the Company will
pay an affiliate of the Sponsor a total of $10,000 per month, for up to 18 months, for office space, utilities and secretarial and
administrative support. Upon completion of the Company’s initial Business Combination or its liquidation, the Company will cease
paying these monthly fees. For the three and nine months ended September 30, 2023, the Company incurred and paid $30,000 and $90,000 of
administrative service fees, respectively. For the three and nine months ended September 30, 2022, the Company incurred $30,000 and $75,000
of administrative service fees, respectively, $30,000 of which were fully paid. As of September 30, 2023 and December 31, 2022, payables
related to the administrative service fee amounted to $0 and $0.
Due to Related Party
At September 30, 2023 and
December 31, 2022, the Company had $889 and $5,059 due to a related party, respectively.
Due from Sponsor
Due from Sponsor is a non-interest-bearing
advance and is due on demand. At September 30, 2023 and December 31, 2022, $3,047 is included in due from sponsor in the accompanying
condensed consolidated balance sheets.
Note 6 — Commitments and Contingencies
Registration and Stockholder Rights
The holders of the Founder
Shares, Private Placement Units, the Private Placement Warrant, and the shares of Class A common stock underlying the Private Placement
Warrants will have registration rights to require the Company to register a sale of any of the Company’s securities held by them
pursuant to a registration rights agreement that was signed prior to or on the effective date of the IPO. These holders will be entitled
to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the
Securities Act. In addition, these holders will have “piggyback” registration rights to include their securities in other
registration statements filed by the Company. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback”
registration rights after five and seven years, respectively, after the effective date of the registration statement of which the
IPO forms a part and may not exercise their demand rights on more than one occasion.
Underwriting Agreement
The underwriters had a 45-day
option from the date of the IPO to purchase up to an additional 1,875,000 Units to cover over-allotments, if any. As of February
15, 2022, the underwriters had fully exercised the over-allotment option.
On December 14, 2021, the
Company sold an aggregate of 355,000 shares of Class B common stock to A.G.P. at $0.007 per share, for a total consideration of $2,470,
and was recorded as share subscription receivable. The subscription receivable was paid on February 18, 2022.
The fair value of Class B
common stock sold to A.G.P. was $1,974,868. The Company accounted for $1,972,398 of the excess of the fair value of Class B common
stock issued to underwriters over the share subscription receivable as an offering cost of the IPO and allocated such amount between the
warrants, equity and temporary equity based on the relative fair values.
On February 15, 2022, the
Company paid cash underwriting commissions of $1,437,500 to the underwriters.
Business Combination Marketing Agreement
The Company engaged A.G.P.
as an advisor in connection with the Business Combination to assist the Company in holding meetings with its stockholders to discuss the
potential Business Combination and the target business’ attributes, to introduce the Company to potential investors that are interested
in purchasing its securities in connection with the initial Business Combination, and to assist the Company with its press releases and
public filings in connection with the Business Combination. The Company will pay A.G.P. a fee in cash for such services upon the consummation
of the initial Business Combination in an amount equal to 3.5% of the gross proceeds of the IPO, or $5,031,250 in the aggregate.
Pursuant to the terms of the Business Combination marketing agreement, no fee will be due if the Company does not complete an initial
Business Combination.
Business Combination Agreement
On February 13, 2023, the
Company entered into a Business Combination Agreement (the “Business Combination Agreement”) by and among (i) the Company
(ii) Relativity Holdings Inc., a Delaware corporation and a wholly-owned subsidiary of Relativity (“Pubco”), (iii) Relativity
Purchaser Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (the “Merger Sub”), (iv) SVES GO,
LLC, a Florida limited liability company, SVES LLC, a Florida limited liability company, SVES CP LLC, a Florida limited liability company
and SVES Apparel LLC, a Florida limited liability company (collectively, the “Operating Companies” or “SVES”),
(v) SVGO LLC, ESGO LLC, SV Apparel LLC, and ES Business Consulting LLC (each a “Seller”), (vi) Timothy J. Fullum and Salomon
Murciano, (vii) the Sponsor and (viii) Timothy J. Fullum. SVES is a key intermediary connecting full-price fashion brands with off-price
retailers that are able to sell inventory that would otherwise be sold or disposed of by full-price brands at a significant loss. At the
closing of the transactions contemplated by the Business Combination Agreement (the “Closing”), in accordance with the DGCL,
(a) the Merger Sub will merge with and into the Company, with the Company surviving the Business Combination as a wholly-owned subsidiary
of Pubco, and (b) each Seller will contribute all of its ownership interest in each Operating Company to Pubco in exchange for aggregate
consideration in the amount of $632,000,000, to be paid in the common stock of Pubco valued at $10.00 per share of common stock. At the
Closing, each public warrant of the Company will be converted into one Pubco public warrant and each private warrant of the Company will
be converted into one Pubco private warrant, in each case with such Pubco warrant having substantially the same terms and conditions as
set forth in the respective Company warrants, except that in each case they will represent the right to acquire shares of Pubco common
stock in lieu of shares of Class A common stock.
On April 19, 2023, the Company,
the Purchaser Representative and the Seller Representative entered into the Second Amendment to the Business Combination Agreement (the
“Second BCA Amendment”) pursuant to which the parties amended the Business Combination Agreement, as amended, in order (i)
to extend the date by which the Seller Representative is required to deliver Audited Company Financials to the Company from April 7, 2023
to May 1, 2023, (ii) to extend the period of time in which the Company may conduct additional due diligence on SVES (the “Due Diligence
Period”) from 5:00 p.m. on April 7, 2023 to 5:00 p.m. May 1, 2023 and (iii) in connection with the transactions contemplated by
the Business Combination Agreement, to permit the Company, subject to receiving any required consent from the holders of Public Warrants,
to convert the Public Warrants into Class A common stock in a manner and amount to be specified in the Proxy Statement and approved by
the Seller Representative, which Class A common stock would be converted automatically into the right to receive one share of Pubco common
stock at the Closing.
On August 11, 2023, the parties
entered into a Third Amendment to the Business Combination Agreement, pursuant to which the parties amended the Business Combination Agreement
in order to, among other things, (i) extend the Due Diligence Period and the date of the required delivery of disclosure schedules to
August 31, 2023, (ii) provide for a proposal in the Proxy Statement to approve an amendment to the Company’s current charter to
eliminate the requirement that the Company retain at least $5,000,001 of net tangible assets following the redemption of the Company’s
public shares in connection with the Business Combination, and to further amend the closing condition in the Business Combination Agreement
such that the Company would not be required to retain at least $5,000,001 of net tangible assets following the redemption of public shares
in the event such proposal is approved, and (iii) extend the Outside Date to February 15, 2024.
Promissory Note with SVES
On
August 10, 2023, the Company issued a promissory note to SVES LLC under which SVES LLC agreed to extend to the Company $300,000 for working
capital purposes. The promissory note is non-interest bearing and payable on the Closing. In
the event the transactions contemplated by the Business Combination Agreement are not consummated, this promissory note shall be null
and void and the Company shall not have any obligation to the payee. As of September 30, 2023, SVES LLC had funded $0 on the promissory
note.
Note 7 — Fair Value Measurement
The following tables present
information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of September 30,
2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair
value. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar
sources to determine the fair value of its investments in the Mutual Fund.
| |
September 30, 2023 | | |
Quoted Prices In Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Mutual Fund held in Trust Account | |
$ | 1,723,615 | | |
$ | 1,723,615 | | |
$ | — | | |
$ | — | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Public Warrants | |
$ | 677,062 | | |
$ | — | | |
$ | 677,062 | | |
$ | — | |
Private Warrants | |
| 30,791 | | |
| — | | |
| — | | |
| 30,791 | |
Warrant Liabilities | |
$ | 707,853 | | |
$ | — | | |
$ | 677,062 | | |
$ | 30,791 | |
| |
December 31, 2022 | | |
Quoted Prices In Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Mutual Fund held in Trust Account | |
$ | 1,671,810 | | |
$ | 1,671,810 | | |
$ | — | | |
$ | — | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Public Warrants | |
$ | 432,688 | | |
$ | — | | |
$ | 432,688 | | |
$ | — | |
Private Warrants | |
| 20,434 | | |
| — | | |
| — | | |
| 20,434 | |
Warrant Liabilities | |
$ | 453,122 | | |
$ | — | | |
$ | 432,688 | | |
$ | 20,434 | |
Transfers to/from Levels
1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were
no transfers to/from during the three and nine months ended September 30, 2023 and 2022.
The warrants were initially
classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. The subsequent measurement of the Public
Warrants is classified as Level 1 due to the use of an observable market price of these warrants. On December 31, 2022 and September 30,
2023, the Public Warrants were reclassified to Level 2 as no trading activity took place on the reporting dates. The estimated fair value
of the Private Placement Warrants at September 30, 2023 was determined using Level 3 inputs. Inherent in a Monte Carlo options pricing
model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company
estimates the volatility of its common stock based on projected volatility of comparable public companies that matches the expected remaining
life of the warrants. The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve on the grant date for a maturity
similar to the expected remaining life of the warrants. The expected life of the warrants is based on management assumptions regarding
the timing and likelihood of completing a business combination. The dividend rate is based on the historical rate, which the Company anticipates
to remain at zero.
The following table provides
quantitative information regarding Level 3 fair value measurements as of September 30, 2023 and December 31, 2022:
| |
September 30,
2023 | | |
December 31, 2022 | |
Strike price | |
$ | 12.28 | | |
$ | 12.65 | |
Share price | |
$ | 10.00 | | |
$ | 10.00 | |
Volatility | |
| — | % | |
| 7.20 | % |
Risk-free rate | |
| 5.47 | % | |
| 4.73 | % |
Expected term (years) | |
| 0.91 | | |
| 0.96 | |
The change in the fair value of the warrant liabilities, measured using
Level 3 inputs, for the three and nine months ended September 30, 2023 and 2022 is summarized as follows:
| |
Warrant | |
| |
Liability | |
Warrant liabilities at December 31, 2022 | |
$ | 20,434 | |
Change in fair value of warrant liabilities | |
| 10,357 | |
Warrant liabilities at March 31, 2023 | |
| 30,791 | |
Change in fair value of warrant liabilities | |
| — | |
Warrant liabilities at June 30, 2023 | |
| 30,791 | |
Change in fair value of warrant liabilities | |
| — | |
Warrant liabilities at September 30, 2023 | |
$ | 30,791 | |
| |
| | |
Warrant liabilities at December 31, 2021 | |
$ | — | |
Issuance of Public and Private Placement Warrants | |
| 4,809,888 | |
Change in fair value of warrant liabilities | |
| (1,894,764 | ) |
Warrant liabilities at March 31, 2023 | |
| 2,915,124 | |
Change in fair value of warrant liabilities | |
| (1,562,005 | ) |
Transfer to Level 2 | |
| (1,293,750 | ) |
Warrant liabilities at June 30, 2023 | |
| 59,369 | |
Change in fair value of warrant liabilities | |
| (19,573 | ) |
Warrant liabilities at September 30, 2023 | |
$ | 39,796 | |
Note 8 — Warrant Liability
As of September 30, 2023
and December 31, 2022, there were 15,028,750 warrants outstanding, respectively. The Company accounted for the 15,028,750 warrants
issued in connection with the IPO (14,375,000 Public Warrants and 653,750 Private Placement Warrants) in accordance with
the guidance contained in ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment
thereunder, each warrant must be recorded as a liability. Accordingly, the Company classifies each warrant as a liability at its fair
value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability is
adjusted to fair value, with the change in fair value recognized in the Company’s condensed consolidated statements of operations.
Each whole warrant entitles
the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment
as described herein. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities
for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price
of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith
by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into
account any Founder Shares held by the Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the
aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for
the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions),
and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading
day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”)
is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher
of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption
of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to
be equal to 180% of the higher of the Market Value and the Newly Issued Price.
The warrants will become
exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of
this offering and will expire at 5:00 p.m., New York City time on the warrant expiration date, which is five years
after the completion of the initial Business Combination or earlier upon redemption or liquidation. On the exercise of any warrant, the
warrant exercise price will be paid directly to the Company and not placed in the Trust Account.
The Company will not be obligated
to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant
exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the
warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying the Company’s
obligations described below with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue
shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has
been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the
warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the
holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event
will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised
warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of
Class A common stock underlying such unit.
The Company has agreed that
as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company
will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon
exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those
shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration
statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 52nd day
after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement
and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the
Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies
the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option,
require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement,
and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable
blue sky laws to the extent an exemption is not available.
Redemption of warrants when the price per share
of Class A common stock equals or exceeds $18.00.
Once the warrants become
exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
|
● |
in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
|
● |
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and |
| ● | if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. |
Note 9 — Stockholders’ (Deficit) Equity
Preferred Stock
The Company is authorized
to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2023 and December
31, 2022, there were no shares of preferred stock issued or outstanding.
Class A Common Stock
The Company is authorized
to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A
common stock are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 4,247,499 and 653,750 shares
of Class A common stock issued or outstanding, respectively, excluding 153,295 shares subject to possible redemption.
Class B Common Stock
The Company is authorized
to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Class B
common stock are entitled to one vote for each share. At September 30, 2023 and December 31, 2022, there were 1 and 3,593,750 shares
of Class B common stock issued and outstanding, respectively. At December 31, 2022, there were 468,750 Class B shares that
were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full so that the Founder
Shares would represent, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the IPO (assuming
the Sponsor did not purchase any public shares in the IPO). As of February 15, 2022, the over-allotment option was fully exercised and
such shares were no longer subject to forfeiture.
On February 27, 2023, the
Company issued an aggregate of 3,593,749 shares of its Class A common stock, par value $0.0001 per share, to the Sponsor, A.G.P./Alliance
Global Partners, George Syllantavos and Anastasios Chrysostomidis, the holders of the Company’s Class B common stock, par value
$0.0001 per share, upon the conversion of an equal number of shares of Class B Common Stock (the “Conversion”). The 3,593,749
shares of Class A Common Stock issued in connection with the Conversion are subject to the same restrictions as applied to the shares
of Class B Common Stock before the Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights
and the obligation to vote in favor of an initial business combination, as described in the prospectus for the Company’s initial
public offering. Following the Conversion, there are 4,400,794 shares of Class A Common Stock issued and outstanding and one share of
Class B Common Stock issued and outstanding.
The remaining share of Class B
common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a
one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject
to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities,
are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination,
the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless
the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such
issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B
common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock
outstanding upon completion of the IPO (not including the shares of Class A common stock issuable to the Representative) plus all
shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination
(excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination, any private
placement-equivalent securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company). The Company cannot
determine at this time whether a majority of the holders of the Class B common stock at the time of any future issuance would agree
to waive such adjustment to the conversion ratio. They may waive such adjustment due to (but not limited to) the following: (i) closing
conditions which are part of the agreement for the initial Business Combination; (ii) negotiation with Class A stockholders
on structuring an initial Business Combination; or (iii) negotiation with parties providing financing which would trigger the anti-dilution
provisions of the Class B common stock. If such adjustment is not waived, the issuance would not reduce the percentage ownership
of holders of the Class B common stock, but would reduce the percentage ownership of holders of the Class A common stock. If
such adjustment is waived, the issuance would reduce the percentage ownership of holders of both classes of the Company’s common
stock. Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of
Class A common stock, subject to adjustment as provided above, at any time. The term “equity-linked securities” refers
to any debt or equity securities that are convertible, exercisable or exchangeable for shares of Class A common stock issues in a
financing transaction in connection with the initial Business Combination, including but not limited to a private placement of equity
or debt. Securities could be “deemed issued” for purposes of the conversion rate adjustment if such shares are issuable upon
the conversion or exercise of convertible securities, warrants or similar securities.
Note 10 — Subsequent Events
The Company evaluated subsequent
events and transactions that occurred after the condensed consolidated balance sheet date up to the date that the unaudited condensed
consolidated financial statements were issued. Based on this review, besides the event below, the Company did not identify any subsequent
events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.
On November 9, 2023,
Relativity announced that it had extended the date by which it has to consummate a Business Combination from November 15, 2023 to February
15, 2024.
On November 19, 2023, SVES
LLC funded approximately $16,000 on the promissory note.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations.
References to the “Company,”
“us,” “our” or “we” refer to Relativity Acquisition Corp. The following discussion and analysis of
our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and
notes thereto contained elsewhere in this Quarterly Report on Form 10-Q (the “Report”).
Cautionary Note Regarding Forward-Looking Statements
All statements other than
statements of historical fact included in this Report including, without limitation, statements under this “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans
and objectives of management for future operations, are forward-looking statements. When used in this Report, terminology such as “may,”
“should,” “expect,” “intend,” “will,” “estimate,” “anticipate,”
“believe,” “predict,” “project,” “target,” “budget,” “forecast,”
“could,” “continue,” “plan,” or “potentially” or the negatives of these terms or variations
of them or similar terminology, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements
are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. Actual
results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our
filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are
qualified in their entirety by this paragraph.
The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial
statements and the notes thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set
forth below includes forward-looking statements that involve risks and uncertainties.
Overview
We are a blank-check company
incorporated as a Delaware corporation on April 13, 2021, for the purposes of effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with one or more businesses. We may pursue an initial business combination
target in any business or industry.
Recent Developments
On February 13, 2023, we
entered into the Business Combination Agreement with (i) Pubco, (ii) the Merger Sub, (iii) SVES, (iv) the Sellers, (v) the SVES Founders,
(vi) our sponsor as the purchaser representative, and (vii) Timothy J. Fullum as the seller representative, as was amended on March 20,
2023, and as may be further amended from time to time. SVES is a key intermediary connecting full-price fashion brands with off-price
retailers that are able to sell inventory that would otherwise be sold or disposed of by full-price brands at a significant loss. At the
closing of the SVES Business Combination, in accordance with the DGCL, (a) the Merger Sub will merge with and into the Company, with the
Company surviving the business combination as a wholly-owned subsidiary of Pubco, and (b) each Seller will contribute all of its ownership
interest in each Operating Company to Pubco in exchange for aggregate consideration in the amount of $632,000,000, to be paid in the common
stock of Pubco valued at $10.00 per share of common stock and (c) each of our public warrants will be converted into one Pubco public
warrant and each of our private placement warrants will be converted into one Pubco private warrant, in each case with such Pubco warrant
having substantially the same terms and conditions as set forth in our respective warrants, except that in each case they will represent
the right to acquire shares of Pubco common stock in lieu of shares of our Class A common stock.
On January 12, 2023, we received
a determination letter (the “Determination Letter”) from the Nasdaq Listing Qualifications staff (the “Staff”)
of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the continued listing requirements
of the Nasdaq Listing Rules set forth in (i) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market Value of Listed Securities,
(ii) Listing Rule 5450(b)(2)(B), requiring a minimum 1,100,000 Publicly Held Shares, and (iii) Listing Rule 5450(b)(2)(C), requiring a
minimum of $15 million in Market Value of Publicly Held Shares. In addition, the Determination Letter stated that the Company did not
comply with either of the alternative requirements for continued listing on The Nasdaq Global Market under Listing Rules 5450(b)(1) or
5450(b)(3), or the requirements for continued listing on The Nasdaq Capital Market under Listing Rule 5550. The Determination Letter also
indicated that the Staff had concerns that the Company might no longer comply with the minimum 400 Total Holders requirement of Listing
Rule 5450(a)(2) due to the substantial number of shareholder redemptions and low number of shares remaining outstanding.
On March 2, 2023, Relativity
had a hearing before the Panel to appeal the Staff’s delisting determination. After the hearing, the Panel requested additional
information from Relativity, which was provided on April 12, 2023. On April 20, 2023, the Panel granted Relativity’s request to
continue the listing of its securities on the Nasdaq Capital Market. However, the Panel did not remove the Trading Halt. As of the date
of the issuance of these unaudited condensed consolidated financial statements, the Trading Halt is still in place. At this juncture,
Relativity has not received any indication from Nasdaq as to if or when the Trading Halt will be lifted. There can be no assurance that
the Trading Halt will be lifted prior to the Closing of the Business Combination. Further, it is uncertain if Pubco will be able to meet
Nasdaq’s initial listing requirements to list its securities on Nasdaq, which is a condition to the closing of the Business Combination.
On February 27, 2023, we
issued an aggregate of 3,593,749 shares of Class A common stock to our sponsor, A.G.P., George Syllantavos and Anastasios Chrysostomidis,
the holders of our Class B common stock, upon the conversion of an equal number of shares of Class B common stock. These shares of class
A common stock are subject to the same restrictions as applied to the Class B common stock before the conversion, including, among other
things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination
as described in the prospectus for our initial public offering. Following the conversion, our sponsor was the beneficial owner of 3,033,905
shares of our Class A common stock and one share of our Class B common stock. The sponsor then transferred 533,525 shares of Class A common
stock to certain members of the sponsor. Subsequent to those transfers, the sponsor holds 2,500,380 shares of Class A common stock and
one share of Class B common stock, as well as 653,750 shares of Class A common stock underlying private placement units, which units were
acquired by the sponsor in connection with the Company’s initial public offering.
On March 20, 2023, the Company,
the Purchaser Representative and the Seller Representative entered into the First Amendment to the Business Combination Agreement to extend
the date to conduct additional due diligence on the Target Companies from 5:00 p.m. on March 15, 2023 to 5:00 p.m. on April 7, 2023.
On April 19, 2023, the Company,
the Purchaser Representative and the Seller Representative entered into the Second Amendment to the Business Combination Agreement (the
“Second BCA Amendment”) pursuant to which the parties amended the Business Combination Agreement, as amended, in order (i)
to extend the date by which the Seller Representative is required to deliver Audited Company Financials to the Company from April 7, 2023
to May 1, 2023, (ii) to extend the period of time in which the Company may conduct additional due diligence on SVES (the “Due Diligence
Period”) from 5:00 p.m. on April 7, 2023 to 5:00 p.m. May 1, 2023 and (iii) in connection with the transactions contemplated by
the Business Combination Agreement, to permit the Company, subject to receiving any required consent from the holders of Public Warrants,
to convert the Public Warrants into Class A common stock in a manner and amount to be specified in the Proxy Statement and approved by
the Seller Representative, which Class A common stock would be converted automatically into the right to receive one share of Pubco common
stock at the Closing.
On August 11, 2023, the parties
entered into a Third Amendment to the Business Combination Agreement, pursuant to which the parties amended the Business Combination Agreement
in order to, among other things, (i) extend the Due Diligence Period and the date of the required delivery of disclosure schedules to
August 31, 2023, (ii) provide for a proposal in the Proxy Statement to approve an amendment to the Company’s current charter to
eliminate the requirement that the Company retain at least $5,000,001 of net tangible assets following the redemption of the Company’s
public shares in connection with the Business Combination, and to further amend the closing condition in the Business Combination Agreement
such that the Company would not be required to retain at least $5,000,001 of net tangible assets following the redemption of public shares
in the event such proposal is approved, and (iii) extend the Outside Date to February 15, 2024.
Results of Operations
As of September 30, 2023,
we had not commenced any operations. All activity for the period from April 13, 2021 (inception) through September 30, 2023, relates to
our formation and initial public offering and identifying a target company for a business combination. We will not generate any operating
revenues until after the completion of a business combination, at the earliest. We will generate non-operating income in the form
of interest income from the proceeds derived from the initial public offering and placed in the trust account.
For the three months ended
September 30, 2023, we had net loss of $648,782, which consists of formation and operating costs of $667,382, provision for income taxes
of $3,754, offset by income from investment in trust account of $22,354.
For the nine months ended
September 30, 2023, we had net loss of $2,314,982, which consists of a decrease in the fair value of warrant liability of $254,731, provision
for income taxes of $9,299 and formation and operating costs of $2,109,560, offset by income from investment in trust account of $58,608.
For the three months ended
September 30, 2022, we had net income of $728,646, which consists of income from investment in trust account of $661,801 and change in
fair value of warrant liability of $450,823, offset by formation and operating costs of $255,500 and provision for income taxes of $128,478.
For the nine months ended
September 30, 2022, we had net income of $3,629,536, which consists of income from investment in trust account of $873,620 and change
in fair value of warrant liability of $3,907,592, offset by formation and operating costs of $874,541, warrant issuance cost of $125,175
and provision for income taxes of $151,960.
Liquidity and Capital Resources
As of September 30, 2023, the Company had $25,939 in its operating
bank account and a working capital deficit of $1,418,132.
On February 15, 2022, we
consummated the initial public offering of 14,375,000 Units, including 1,875,000 Units pursuant to the exercise of the underwriters’
over-allotment option in full, at $10.00 per unit, generating gross proceeds of $143,750,000.
Simultaneously with the closing
of the initial public offering, we consummated the sale of 653,750 private placement units at a price of $10.00 per private placement
unit in a private placement to the sponsor, generating total gross proceeds of $6,537,500.
Transaction costs amounted
to $3,890,326 consisting of $1,437,500 of underwriting commissions, $1,972,398 of the excess of the fair value of Class B common stock
issued to underwriter over the share subscription receivable, and $480,428 of other offering costs.
Following the closing of
our initial public offering, $146,625,000 from the net proceeds of the sale of the units in our initial public offering and the sale of
the private placement units was placed in the trust account maintained by Continental, as trustee. In connection with our Special Meeting
held on December 21, 2022, stockholders holding 14,221,705 public shares exercised their right to redeem such shares for a pro rata portion
of the funds in our trust account. As a result, approximately $146 million (approximately $10.29 per public share) was removed from the
trust account to pay such holders. As of September 30, 2023 and December 31, 2022, approximately $1,723,615 and $1,671,810 remained in
the trust account.
In connection with the redemptions
of public shares, a total of $133,689 was deducted from our trust account in order to pay taxes prior to the Special Meeting, which amount
had later been determined to be withheld in excess and should be returned to the public stockholders. As such, a portion of this rebate
was sent to the financial institutions that had submitted share redemptions on behalf of their investor clients ahead of the Special Meeting
and the balance to the trust account. The redemption rebate payments total $132,263 ($0.00930008 per redeemed share), with $1,426 returned
in the trust account.
We intend to use substantially
all of the funds held in the trust account, including any amounts representing interest earned on the trust account to complete our initial
business combination. We may withdraw interest to pay our taxes and liquidation expenses if we are unsuccessful in completing a business
combination. We may pay our franchise tax from funds from the initial public offering held outside of the trust account or from interest
earned on the funds held in the trust account and released to us for this purpose. Our annual income tax obligations will depend on the
amount of interest and other income earned on the amounts held in the trust account reduced by our operating expense and franchise taxes.
We expect the interest earned on the amount in the trust account will be sufficient to pay our income taxes. To the extent that our equity
or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the
trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
Further, our sponsor or an
affiliate of the sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required for
Working Capital Loans. If we complete a business combination, we would repay the Working Capital Loans out of the proceeds of the trust
account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the trust account. In the
event that a business combination does not close, we may use a portion of the working capital held outside the trust account to repay
the Working Capital Loans, but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of
such Working Capital Loans may be convertible into units at a price of $10.00 per unit at the option of the lender. The units would be
identical to the private placement units. At September 30, 2023 and December 31, 2022, no such working capital loans were outstanding.
We do not believe we will
need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the
costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual
amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover,
we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant
number of our public shares upon consummation of our business combination, in which case we may issue additional securities or incur debt
in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing
simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not
have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our
business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
Further, we have determined
that if we are unable to complete a business combination within the Combination Period, then we will (i) cease all operations except for
the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,
at a per-share price, payable in cash and (iii) as promptly as reasonably possible following such redemption, subject to the approval
of our remaining stockholders and our board of directors, dissolve and liquidate. The date for mandatory liquidation and subsequent dissolution
as well as our working capital deficit raise substantial doubt about our ability to continue as a going concern. No adjustments have been
made to the carrying amounts of assets or liabilities should we be required to liquidate after the applicable extension date.
Critical Accounting Policies and Estimates
Emerging Growth Company Status
We are an “emerging
growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including,
but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.
Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which
means that when a standard is issued or revised and it has different application dates for public or private companies, we as an emerging
growth company can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards
used.
Use of Estimates
This management’s
discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared
in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation
of our financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly
from those estimates. We determined the more significant accounting estimates included in our financial statements is the determination
of the fair value of Derivative Financial Instruments.
We have identified the following
as our critical accounting estimates:
Derivative Financial Instruments
We evaluate our financial
instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with
Accounting Standards Codification (“ASC”) Topic 815, “Derivatives and Hedging”. For derivative financial instruments
that are accounted for as liabilities, such as the Company’s public warrants and private placement warrants, the derivative instrument
is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value
reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets
as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months
of the balance sheet date.
The valuation of our public
warrants are based on a traded market. Our private placement warrants are valued using a Monte Carlo options pricing model which utilizes
assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates
the volatility of its common stock based on projected volatility of comparable public companies that matches the expected remaining life
of the warrants. The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve on the grant date for a maturity similar
to the expected remaining life of the warrants. The expected life of the warrants is based on management assumptions regarding the timing
and likelihood of completing a Business Combination. The dividend rate is based on the historical rate, which the Company anticipates
to remain at zero.
The estimates used to calculate
the fair value of our derivative assets and liabilities change at each balance sheet date based on our stock price and other assumptions
described above. If our assumptions change or we experience significant volatility in our stock price or interest rates, the fair value
calculated from one balance sheet period to the next could be materially different.
Common stock Subject to Possible Redemption
Our Class A common stock
that was sold as part of the units in the initial public offering contains a redemption feature which allows for the redemption of such
public shares in connection with our liquidation, or if there is a stockholder vote or tender offer in connection with our initial business
combination. In accordance with ASC Topic 480-10-S99, we classify such public shares subject to redemption outside of permanent equity
as the redemption provisions are not solely within our control. The public shares sold as part of the units in the initial public offering
were issued with other freestanding instruments (i.e., warrants) and as such, the initial carrying value of public shares classified as
temporary equity was the allocated proceeds determined in accordance with ASC Topic 470-20 (“Debt—Debt with Conversion and
Other Options”). The public shares are subject to ASC 480-10-S99 and are currently not redeemable as the redemption is contingent
upon the occurrence of events mentioned above. According to ASC 480-10-S99-15, no subsequent adjustment is needed if it is not probable
that the instrument will become redeemable.
Accordingly, as of September
30, 2023, 153,295 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity,
outside of the shareholders’ equity section of our balance sheet. The change in the carrying value of redeemable shares of Class
A common stock resulted in charges against accumulated deficit.
In connection with the Special
Meeting on December 21, 2022, stockholders holding 14,221,705 shares of Class A common stock exercised their right to redeem such shares
for a pro rata portion of the funds in the trust account (approximately $10.29 per public share). Following the redemptions, as of September
30, 2023 and December 31, 2022, there were a total of 4,400,794 and 807,045 shares of Class A common stock were outstanding, respectively.
Following the conversion of Class B common stock into shares of Class A common stock on February 27, 2023, and subsequent transactions,
there are currently 153,295 public shares outstanding and a total of 4,400,794 shares of Class A common stock are outstanding, including
the 2,500,380 shares of Class A common stock and the one share of Class B common stock that are beneficially owned by our sponsor.
Recent Accounting Standards
In August 2020, Financial
Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt — Debt
with Conversion and Other Options” (Subtopic 470-20), and “Derivatives and Hedging — Contracts in Entity’s Own
Equity” (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all
convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years, with early adoption permitted. We adopted ASU 2020-06 effective as of April 13, 2021. That adoption of ASU 2020-06
did not have an impact on our financial statements.
Management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on
our unaudited condensed financial statements.
Off-Balance Sheet Arrangements
As of September 30, 2023
and December 31, 2022, we did not have any off-balance sheet arrangements.
Factors That May Adversely Affect Our Results
of Operations
Our results of operations
and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty
and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things,
downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply
chain disruptions, declines in consumer confidence and spending, and geopolitical instability, such as the military conflict in the Ukraine.
We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which
they may negatively impact our business and our ability to complete an initial business combination.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk.
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures
that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act,
such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms.
Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management,
including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Our management evaluated, with the participation of our current Chief Executive Officer and Chief Financial Officer (our “Certifying
Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) or
Rule 15d-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2023, our
disclosure controls and procedures were effective.
We do not expect that our
disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how
well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures
are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the
benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no
evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and
instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions.
Changes in Internal Control over Financial Reporting
There have been no changes
to our internal control over financial reporting during the quarter ended September 30, 2023 that materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
To the knowledge of our management
team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such
or against any of our property.
Item 1A. Risk Factors.
As a smaller reporting company
under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, as of the date of this Report,
except as set forth below, there have been no material changes to the risk factors previously disclosed in the Company’s (i) most
recent prospectus for the initial public offering as filed with the February 14, 2022, (ii) its Annual Report on Form 10-K filed with
the SEC on March 31, 2023, and (iii) its Quarterly Reports on Form 10-Q filed with the SEC on May 16, 2022, August 15, 2022, November
14, 2022, May 15, 2023 and August 14, 2023, respectively. Any of these factors could result in a significant or material adverse
effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability
to consummate an initial business combination. We may disclose changes to such risk factors or disclose additional risk factors from time
to time in our future filings with the SEC.
Military or other conflicts in Ukraine,
the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations
or financial condition of potential target companies, which could make it more difficult for us to consummate the Business Combination.
Military or other conflicts
in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the
operations or financial condition of potential target companies, and to other company or industry-specific, national, regional or international
economic disruptions and economic uncertainty, any of which could make it more difficult for us to consummate the Business Combination.
A 1% U.S. federal excise tax may be imposed
on us in connection with our redemptions of shares in connection with a business combination or other stockholder vote pursuant to which
stockholders would have a right to submit their shares for redemption (a “Redemption Event”).
Pursuant to the Inflation
Reduction Act of 2022, commencing in 2023, a 1% U.S. federal excise tax (the “Excise Tax”) is imposed on certain repurchases
(including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded
foreign corporations. The Excise Tax is imposed on the repurchasing corporation and not on its stockholders. The amount of the Excise
Tax is equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating
the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market
value of stock repurchases during the same taxable year. The U.S. Department of the Treasury (the “Treasury Department”) has
authority to promulgate regulations and provide other guidance regarding the Excise Tax. In December 2022, the Treasury Department issued
Notice 2023-2, indicating its intention to propose such regulations and issuing certain interim rules on which taxpayers may rely. Under
the interim rules, liquidating distributions made by publicly traded domestic corporations are exempt from the Excise Tax. In addition,
any redemptions that occur in the same taxable year as a liquidation is completed will also be exempt from such tax. Accordingly, redemptions
of our public shares in connection with an extension of the Combination Period may subject us to the Excise Tax, unless one of the two
exceptions above apply. Such redemptions would only occur if an extension of the Combination Period is approved by our stockholders and
such extension is implemented by the board of directors.
If the deadline for us to
complete a business combination (currently February 15, 2024) is extended, our public stockholders will have the right to require us to
redeem their public shares. Any redemption or other repurchase may be subject to the Excise Tax. The extent to which we would be subject
to the Excise Tax in connection with a Redemption Event would depend on a number of factors, including: (i) the fair market value of the
redemptions and repurchases in connection with the Redemption Event, (ii) the nature and amount of any “PIPE” or other equity
issuances in connection with the business combination (or otherwise issued not in connection with the Redemption Event but issued within
the same taxable year of the business combination), (iii) if we fail to timely consummate a business combination and liquidate in a taxable
year subsequent to the year in which a Redemption Event occurs and (iv) the content of any proposed or final regulations and other
guidance from the Treasury Department. In addition, because the Excise Tax would be payable by us and not by the redeeming holders, the
mechanics of any required payment of the Excise Tax remain to be determined. Any Excise Tax payable by us in connection with a Redemption
Event may cause a reduction in the cash available to us to complete a business combination and could affect our ability to complete a
business combination.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
The following exhibits are filed as part of, or
incorporated by reference into, this Report.
* |
Filed herewith. |
** |
Furnished. |
PART III
SIGNATURES
In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
RELATIVITY ACQUISITION CORP. |
|
|
|
Date: November 20, 2023 |
By: |
/s/ Tarek Tabsh |
|
Name: |
Tarek Tabsh |
|
Title: |
Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
Date: November 20, 2023 |
By: |
/s/ Steven Berg |
|
Name: |
Steven Berg |
|
Title: |
Chief Financial Officer |
|
|
(Principal Accounting and Financial Officer) |
29
12496433
15028750
153295
153295
0.04
0.15
0.23
0.53
3494397
4247499
0.15
0.53
3593750
3593750
753103
1
0.04
0.15
0.23
0.53
15028750
153295
0.04
0.15
4247499
0.15
3593750
1
0.04
0.15
12496433
153295
0.23
0.53
3494397
0.53
3593750
753103
0.23
0.53
P5Y
false
--12-31
Q3
0001860484
0001860484
2023-01-01
2023-09-30
0001860484
racy:UnitsEachConsistingOfOneShareOfClassACommonStockAndOneRedeemableWarrantMember
2023-01-01
2023-09-30
0001860484
racy:ClassACommonStockParValue00001PerShareMember
2023-01-01
2023-09-30
0001860484
racy:RedeemableWarrantsEachWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150Member
2023-01-01
2023-09-30
0001860484
2023-11-20
0001860484
2023-09-30
0001860484
2022-12-31
0001860484
us-gaap:CommonClassAMember
2023-09-30
0001860484
us-gaap:CommonClassAMember
2022-12-31
0001860484
us-gaap:CommonClassBMember
2023-09-30
0001860484
us-gaap:CommonClassBMember
2022-12-31
0001860484
2023-07-01
2023-09-30
0001860484
2022-07-01
2022-09-30
0001860484
2022-01-01
2022-09-30
0001860484
racy:ClassACommonStockSubjectToPossibleRedemptionMember
2023-07-01
2023-09-30
0001860484
racy:ClassACommonStockSubjectToPossibleRedemptionMember
2022-07-01
2022-09-30
0001860484
racy:ClassACommonStockSubjectToPossibleRedemptionMember
2023-01-01
2023-09-30
0001860484
racy:ClassACommonStockSubjectToPossibleRedemptionMember
2022-01-01
2022-09-30
0001860484
us-gaap:CommonClassAMember
2023-07-01
2023-09-30
0001860484
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
2023-07-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
2022-07-01
2022-09-30
0001860484
us-gaap:CommonClassBMember
2023-01-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
2022-01-01
2022-09-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-12-31
0001860484
us-gaap:RetainedEarningsMember
2022-12-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-01-01
2023-03-31
0001860484
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001860484
2023-01-01
2023-03-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-03-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-03-31
0001860484
us-gaap:RetainedEarningsMember
2023-03-31
0001860484
2023-03-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-04-01
2023-06-30
0001860484
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001860484
2023-04-01
2023-06-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-06-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-06-30
0001860484
us-gaap:RetainedEarningsMember
2023-06-30
0001860484
2023-06-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-07-01
2023-09-30
0001860484
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-09-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2023-09-30
0001860484
us-gaap:RetainedEarningsMember
2023-09-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-12-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2021-12-31
0001860484
us-gaap:RetainedEarningsMember
2021-12-31
0001860484
2021-12-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-01-01
2022-03-31
0001860484
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001860484
2022-01-01
2022-03-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-03-31
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-03-31
0001860484
us-gaap:RetainedEarningsMember
2022-03-31
0001860484
2022-03-31
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-04-01
2022-06-30
0001860484
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001860484
2022-04-01
2022-06-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-06-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-06-30
0001860484
us-gaap:RetainedEarningsMember
2022-06-30
0001860484
2022-06-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-07-01
2022-09-30
0001860484
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001860484
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-09-30
0001860484
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-09-30
0001860484
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001860484
us-gaap:ReceivablesFromStockholderMember
2022-09-30
0001860484
us-gaap:RetainedEarningsMember
2022-09-30
0001860484
2022-09-30
0001860484
2022-02-15
2022-02-15
0001860484
us-gaap:IPOMember
2022-02-15
0001860484
2022-02-15
0001860484
us-gaap:CommonClassAMember
2022-02-15
0001860484
us-gaap:IPOMember
2023-09-30
0001860484
racy:SponsorMember
2023-01-01
2023-09-30
0001860484
racy:SponsorMember
2023-09-30
0001860484
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-09-30
0001860484
us-gaap:OverAllotmentOptionMember
2022-02-15
2022-02-15
0001860484
us-gaap:IPOMember
2022-02-15
2022-02-15
0001860484
2023-08-03
0001860484
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-01-01
2023-09-30
0001860484
2023-01-12
0001860484
us-gaap:CommonClassAMember
2022-12-01
2022-12-28
0001860484
2022-08-16
2022-08-16
0001860484
2023-04-01
2023-09-30
0001860484
racy:WarrantLiabilityMember
2023-07-01
2023-09-30
0001860484
racy:WarrantLiabilityMember
2022-07-01
2022-09-30
0001860484
racy:WarrantLiabilityMember
2023-01-01
2023-09-30
0001860484
racy:WarrantLiabilityMember
2022-01-01
2022-09-30
0001860484
us-gaap:CommonClassAMember
2022-07-01
2022-09-30
0001860484
us-gaap:CommonClassAMember
2022-01-01
2022-09-30
0001860484
us-gaap:OverAllotmentOptionMember
2022-02-15
0001860484
us-gaap:IPOMember
2023-01-01
2023-09-30
0001860484
2022-01-01
2022-12-31
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2022-01-01
2022-12-31
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2022-12-31
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-01-01
2023-03-31
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-03-31
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-04-01
2023-06-30
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-06-30
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-07-01
2023-09-30
0001860484
racy:CommonStockSubjectToPossibleRedemptionMember
2023-09-30
0001860484
racy:SponsorMember
2023-01-01
2023-09-30
0001860484
racy:SponsorMember
2023-09-30
0001860484
us-gaap:PrivatePlacementMember
2023-01-01
2023-09-30
0001860484
2021-05-31
0001860484
racy:FounderSharesMember
us-gaap:CommonStockMember
2021-05-31
0001860484
racy:FounderSharesMember
2021-12-01
2021-12-14
0001860484
us-gaap:CommonClassBMember
2021-12-01
2021-12-14
0001860484
us-gaap:CommonClassBMember
2021-12-14
0001860484
racy:GeorgeSyllantavosMember
2022-01-01
2022-01-12
0001860484
racy:AnastasiosChrysostomidisMember
2022-01-01
2022-01-12
0001860484
us-gaap:IPOMember
2022-01-01
2022-01-12
0001860484
2022-01-12
0001860484
us-gaap:CommonClassAMember
racy:SponsorMember
2023-02-27
2023-02-27
0001860484
us-gaap:CommonClassAMember
2023-02-27
0001860484
us-gaap:CommonClassBMember
2023-02-27
2023-02-27
0001860484
us-gaap:CommonClassAMember
racy:SponsorMember
2023-02-27
0001860484
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2023-02-27
0001860484
us-gaap:CommonClassBMember
racy:SponsorMember
2023-01-01
2023-09-30
0001860484
us-gaap:IPOMember
2021-07-02
2021-07-02
0001860484
2021-07-02
2021-07-02
0001860484
us-gaap:PrivatePlacementMember
2023-09-30
0001860484
us-gaap:OverAllotmentOptionMember
2023-01-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
2021-12-14
2021-12-14
0001860484
2021-12-14
2021-12-14
0001860484
racy:BusinessCombinationMember
2023-09-30
0001860484
us-gaap:CommonStockMember
2023-09-30
0001860484
racy:NetTangibleAssetsMember
2023-04-19
0001860484
2023-04-19
0001860484
2023-08-10
0001860484
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001860484
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001860484
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001860484
racy:PublicWarrantsMember
2023-09-30
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001860484
racy:PrivateWarrantsMember
2023-09-30
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001860484
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001860484
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001860484
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001860484
racy:PublicWarrantsMember
2022-12-31
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001860484
racy:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001860484
racy:PrivateWarrantsMember
2022-12-31
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001860484
racy:PrivateWarrantsMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001860484
us-gaap:WarrantMember
2023-09-30
0001860484
us-gaap:WarrantMember
2023-01-01
2023-09-30
0001860484
us-gaap:CommonClassBMember
2022-01-01
2022-12-31
0001860484
us-gaap:CommonClassBMember
2023-02-27
0001860484
us-gaap:CommonClassAMember
2023-02-27
2023-02-27
0001860484
srt:ScenarioForecastMember
2023-11-19
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of Relativity
Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023,
as filed with the Securities and Exchange Commission on the date hereof (the “Report”) on the date hereof, I, Tarek Tabsh,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:
In connection with the Quarterly Report of Relativity
Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023,
as filed with the Securities and Exchange Commission on the date hereof (the “Report”) on the date hereof, I, Steven Berg,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge: